Loading...
XHKG
8372
Market cap14mUSD
Jul 08, Last price  
0.14HKD
1Q
8.59%
IPO
-57.88%
Name

Grand Brilliance Group Holdings Ltd

Chart & Performance

D1W1MN
XHKG:8372 chart
P/E
13.22
P/S
1.10
EPS
0.01
Div Yield, %
1.80%
Shrs. gr., 5y
Rev. gr., 5y
7.47%
Revenues
101m
+6.63%
52,876,00051,657,00053,703,00058,045,00067,227,00070,241,00071,978,00076,701,00081,903,00094,448,000100,713,000
Net income
8m
-11.07%
12,979,00011,802,000-3,080,0006,608,0009,566,0007,859,0004,048,0007,562,0007,855,0009,460,0008,413,000
CFO
0k
-100.00%
15,908,0004,747,0003,296,000-3,177,00021,625,0006,012,000-3,334,00012,658,0006,718,0001,352,0000
Dividend
Jul 14, 20250.0025 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposables, specialized instruments, and advanced medical machinery. The company also undertakes the development of innovative healthcare products. Beyond product distribution, it delivers comprehensive medical device solutions such as in-depth market trend assessments, strategic sourcing, post-sale support, technical training, equipment rental, and stringent quality assurance. Additionally, the firm manages maintenance services and holds several registered trademarks. Its diverse client base spans both public and private healthcare facilities, independent clinics, charitable groups, academic institutions, and direct consumers. Established in 1997, the company is headquartered in Tsuen Wan, Hong Kong, and operates as a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT